Do existing LLM benchmark scores reflect real-world performance?

Why do benchmark scores overestimate real-world ability?

Standard benchmarks typically test LLMs on static, independent questions, but real-world tasks often require iterative learning, tool use, and handling ambiguous or sensitive data. A 2025 survey of LLM capabilities noted that existing benchmark-based assessments often fail to capture real-world performance because the required capabilities differ from those measured [3]. For instance, in a clinical decision task, agentic AI systems (which can browse the web, run code, and edit files) achieved only 30.3% accuracy on MedAgentsBench, a medical QA dataset, despite access to advanced tools [1]. This is far below the near-perfect scores these same models often post on popular benchmarks like MMLU.

Another study introduced a framework called LLM-Evolve, which tests models over multiple rounds with feedback, mimicking real-world learning. They found that models improved up to 17% from past interactions, but standard i.i.d. (independent and identically distributed) benchmarks completely miss this dynamic capability [4]. This means a model's static benchmark score can be misleadingly high or low compared to how it performs when it must adapt over time.

How do LLMs perform in high-stakes fields like medicine and finance?

In medicine, the gap between benchmark scores and real-world reliability is stark. A randomized, single-blind evaluation by 27 experienced clinicians (averaging 25.9 years of practice) tested seven top LLMs on 685 real and simulated clinical cases. The top models scored only around 6.0 out of 10 on medical strength—equivalent to a physician with 6 years of experience—and 40 instances of hallucinations were documented, including fabricated conditions and medications [2]. Another study on precision oncology found that medium-scale LLMs gave outdated or incorrect information in a large percentage of answers, with high disagreement among expert evaluators about correctness [6]. The authors concluded that there is a clear gap between benchmark- and real-world performance.

In finance, a 2025 review highlighted that while LLMs like GPT-4 and Claude can extract structured knowledge from earnings calls and reports, they still suffer from hallucination, bias, and difficulty explaining reasoning—problems that standard benchmarks do not adequately capture [5]. The review emphasized that human oversight remains essential for high-stakes financial decisions, directly contradicting the impression of competence that high benchmark scores might give.

What are the hidden costs of using LLMs in practice?

Even when LLMs show modest real-world gains, they come with steep computational and safety costs. In the clinical agent study, the best agent systems used over 10 times more tokens and had more than 2 times the latency compared to baseline LLMs, yet only achieved modest accuracy improvements (e.g., 60.3% on AgentClinic MedQA vs. lower baseline scores) [1]. Despite built-in safeguards filtering 89.9% of hallucinations, the remaining errors still posed risks. This means that deploying LLMs in real-world settings is not just about accuracy—it also involves significant resource demands and persistent safety concerns that benchmarks rarely reflect.

Sources used in this answer

Related research questions